Seroprevalence of Leptospirosis in Val Müstair, Switzerland
Leptospirosis, Tularaemia and Hepatitis E in a Rural Mountain Valley in the Alpine Region of Switzerland - A Cross-sectional Exploratory Seroprevalence Study
Sponsor: Cantonal Hospital of St. Gallen
A observational or N/A phase clinical study on Hepatitis E Virus Infection and Leptospirosis, this trial is completed. The trial is conducted by Cantonal Hospital of St. Gallen and has accumulated 6 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Completed
-
Jan 2025 — Jan 2026 [monthly]
Completed
Status: Recruiting → Completed
-
Sep 2024 — Jan 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 1 earlier version
-
Apr 2022 — Nov 2023 [monthly]
Recruiting
First recorded
Mar 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cantonal Hospital of St. Gallen
- University Hospital, Basel, Switzerland
For direct contact, visit the study record on ClinicalTrials.gov .